Walleye Capital’s Editas Medicine EDIT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-48,100	Closed	-$98.6K	–	4543
2025 Q4	$98.6K	Buy	48,100 +21,600	+82%	+$62.4K	﹤0.01%	3874
2025 Q3	$92K	Buy	+26,500	New	+$74K	﹤0.01%	3744
2025 Q1	–	Sell	-16,700	Closed	-$21.2K	–	4451
2024 Q4	$21.2K	Sell	16,700 -31,000	-65%	-$79K	﹤0.01%	4493
2024 Q3	$163K	Buy	47,700 +41,700	+695%	+$182K	﹤0.01%	4141
2024 Q2	$28K	Buy	6,000 +5,700	+1,900%	+$32.2K	﹤0.01%	5060
2024 Q1	$2.23K	Buy	+300	New	+$2.49K	﹤0.01%	5254
2023 Q2	–	Sell	-37,200	Closed	-$270K	–	4441
2023 Q1	$270K	Sell	37,200 -300	-0.8%	-$2.67K	﹤0.01%	2211
2022 Q4	$333K	Buy	37,500 +28,800	+331%	+$316K	0.01%	1715
2022 Q3	$106K	Buy	+8,700	New	+$136K	﹤0.01%	2398
2020 Q2	–	Sell	-6,000	Closed	-$119K	–	699
2020 Q1	$119K	Sell	6,000 -17,200	-74%	-$434K	0.03%	561
2019 Q4	$687K	Buy	23,200 +500	+2%	+$12.5K	0.04%	545
2019 Q3	$516K	Buy	22,700 +9,100	+67%	+$225K	0.03%	736
2019 Q2	$336K	Buy	13,600 +7,100	+109%	+$169K	0.04%	682
2019 Q1	$159K	Buy	+6,500	New	+$147K	0.03%	861